Zhao Bo, Li Guang-Ping, Peng Jian-Jun, Ren Li-Hui, Lei Li-Cheng, Ye Hui-Ming, Wang Zuo-Yan, Zhao Sheng
Department of Cardiology, Beijing Shijitan Hospital, Capital Medical University, Beijing 100038, P.R. China.
Department of Cardiology, Tianjin Key Laboratory of Ionic-Molecular Function of Cardiovascular Disease, Tianjin Institute of Cardiology, The Second Hospital of Tianjin Medical University, Tianjin 300211, P.R. China.
Exp Ther Med. 2021 Mar;21(3):220. doi: 10.3892/etm.2021.9651. Epub 2021 Jan 18.
Schizandrin B exhibits prominent antioxidant and anti-inflammatory effects, and plays an important role in ameliorating myocardial ischemia/reperfusion injury. However, the underlying protective mechanisms remain to be elucidated. The aim of the present study was to explore the cardioprotective effects of schizandrin B against hypoxia/reoxygenation (H/R)-induced H9c2 cell injury, focusing on the role of the adenosine monophosphate-activated protein kinase (AMPK)/nuclear factor erythroid 2-related factor 2 (Nrf2) pathway in this process. The results showed that schizandrin B attenuated the H/R-induced decrease in cell viability and the increase in lactate dehydrogenase release, as well as the apoptosis rate in H9c2 cells. Schizandrin B also mitigated H/R-induced oxidative stress, as illustrated by the decrease in intracellular reactive oxygen species generation, malondialdehyde content and NADPH oxidase 2 expression, and the increase in antioxidant enzyme superoxide dismutase and glutathione peroxidase activities. In addition, schizandrin B reversed the H/R-induced upregulation of pro-inflammatory cytokines [interleukin (IL)-1β (IL-1β) tumor necrosis factor-α, IL-6 and IL-8] and the downregulation of anti-inflammatory cytokines (transforming growth factor-β and IL-10) in the culture supernatant. Notably, schizandrin B increased the expression of Nrf2, NAD(P)H: Quinone oxidoreductase (NQO-1) and heme oxygenase-1 (HO-1) in H/R-treated H9c2 cells, activating the Nrf2 signaling pathway. The cardioprotection of schizandrin B against H/R injury was inhibited by Nrf2 knockdown induced byNrf-2-specific small interfering RNA (siRNA; si-Nrf2) transfection. Furthermore, schizandrin B enhanced phosphorylated (p)-AMPK expression, while AMPK knockdown induced by AMPK-specific siRNA(si-AMPK) transfection remarkably eliminated schizandrin B-induced cardioprotection and reduced Nrf2 expression in H/R-treated H9c2 cells. Taken together, these results suggested that schizandrin B exerts cardioprotection on H/R injury in H9c2 cells due to its antioxidant and anti-inflammatory activities via activation of the AMPK/Nrf2 pathway.
五味子乙素具有显著的抗氧化和抗炎作用,在改善心肌缺血/再灌注损伤中发挥重要作用。然而,其潜在的保护机制仍有待阐明。本研究旨在探讨五味子乙素对缺氧/复氧(H/R)诱导的H9c2细胞损伤的心脏保护作用,重点关注腺苷酸活化蛋白激酶(AMPK)/核因子红细胞2相关因子2(Nrf2)通路在此过程中的作用。结果表明,五味子乙素减轻了H/R诱导的细胞活力下降、乳酸脱氢酶释放增加以及H9c2细胞的凋亡率。五味子乙素还减轻了H/R诱导的氧化应激,表现为细胞内活性氧生成减少、丙二醛含量降低、NADPH氧化酶2表达下降以及抗氧化酶超氧化物歧化酶和谷胱甘肽过氧化物酶活性增加。此外,五味子乙素逆转了H/R诱导的培养上清液中促炎细胞因子[白细胞介素(IL)-1β、肿瘤坏死因子-α、IL-6和IL-8]的上调以及抗炎细胞因子(转化生长因子-β和IL-10)的下调。值得注意的是,五味子乙素增加了H/R处理的H9c2细胞中Nrf2、NAD(P)H:醌氧化还原酶(NQO-1)和血红素加氧酶-1(HO-1)的表达,激活了Nrf2信号通路。Nrf-2特异性小干扰RNA(siRNA;si-Nrf2)转染诱导的Nrf2敲低抑制了五味子乙素对H/R损伤的心脏保护作用。此外,五味子乙素增强了磷酸化(p)-AMPK的表达,而AMPK特异性siRNA(si-AMPK)转染诱导的AMPK敲低显著消除了五味子乙素诱导的心脏保护作用,并降低了H/R处理的H9c2细胞中Nrf2的表达。综上所述,这些结果表明五味子乙素通过激活AMPK/Nrf2通路,因其抗氧化和抗炎活性而对H9c2细胞的H/R损伤发挥心脏保护作用。